Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease

Sise ME, Chute DF, Oppong Y, et al. Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease. Kidney Int. 2020;97(1):193-201.

Publication Type:

Journal Article

Authors:

Sise, Meghan E.; Chute, Donald F; Oppong, Yaa; et, al

Source:

Kidney Int., Volume 97, Issue 1, p.193-201 (2020)

Notes:

Epub 2019 May 15

Cited On:

Patients with Renal Impairment

Export Citation:

RIS Format

Top